NewSquare Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Buy |
27,626
+1,206
| +5% | +$65.4K | 0.13% | 128 |
|
|
2025
Q4 | $1.3M | Buy |
+26,420
| New | +$1.23M | 0.11% | 122 |
|
|
2025
Q3 | – | Sell |
-410
| Closed | -$15.7K | – | 608 |
|
|
2025
Q2 | $15.7K | Sell |
410
-582
| -59% | -$22.2K | ﹤0.01% | 533 |
|
|
2025
Q1 | $38.4K | Buy |
992
+777
| +361% | +$28.4K | ﹤0.01% | 262 |
|
|
2024
Q4 | $7.27K | Buy |
215
+108
| +101% | +$3.89K | ﹤0.01% | 311 |
|
|
2024
Q3 | $4.37K | Hold |
107
| – | – | ﹤0.01% | 255 |
|
|
2024
Q2 | $4.12K | Hold |
107
| – | – | ﹤0.01% | 267 |
|
|
2024
Q1 | $4.59K | Hold |
107
| – | – | ﹤0.01% | 300 |
|
|
2023
Q4 | $3.96K | Hold |
107
| – | – | ﹤0.01% | 332 |
|
|
2023
Q3 | $3.88K | Sell |
107
-16
| -13% | -$568 | ﹤0.01% | 397 |
|
|
2023
Q2 | $4.38K | Sell |
123
-320
| -72% | -$11.5K | ﹤0.01% | 437 |
|
|
2023
Q1 | $15.8K | Hold |
443
| – | – | ﹤0.01% | 297 |
|
|
2022
Q4 | $15.6K | Buy |
443
+336
| +314% | +$11.2K | ﹤0.01% | 246 |
|
|
2022
Q3 | $3K | Hold |
107
| – | – | ﹤0.01% | 329 |
|
|
2022
Q2 | $6K | Hold |
107
| – | – | ﹤0.01% | 277 |
|
|
2022
Q1 | $6K | Hold |
107
| – | – | ﹤0.01% | 299 |
|
|
2021
Q4 | $6K | Hold |
107
| – | – | ﹤0.01% | 313 |
|
|
2021
Q3 | $5K | Hold |
107
| – | – | ﹤0.01% | 316 |
|
|
2021
Q2 | $5K | Hold |
107
| – | – | ﹤0.01% | 304 |
|
|
2021
Q1 | $5K | Sell |
107
-80
| -43% | -$3.63K | ﹤0.01% | 284 |
|
|
2020
Q4 | $9K | Hold |
187
| – | – | ﹤0.01% | 240 |
|
|
2020
Q3 | $9K | Sell |
187
-108
| -37% | -$5.41K | ﹤0.01% | 233 |
|
|
2020
Q2 | $15K | Buy |
295
+108
| +58% | +$5.54K | ﹤0.01% | 206 |
|
|
2020
Q1 | $9K | Hold |
187
| – | – | ﹤0.01% | 244 |
|
|
2019
Q4 | $11K | Hold |
187
| – | – | ﹤0.01% | 227 |
|
|
2019
Q3 | $10K | Hold |
187
| – | – | ﹤0.01% | 193 |
|
|
2019
Q2 | $9K | Hold |
187
| – | – | ﹤0.01% | 255 |
|
|
2019
Q1 | $10K | Hold |
187
| – | – | ﹤0.01% | 241 |
|
|
2018
Q4 | $9K | Sell |
187
-375
| -67% | -$18.5K | ﹤0.01% | 232 |
|
|
2018
Q3 | $28K | Hold |
562
| – | – | 0.01% | 196 |
|
|
2018
Q2 | $29K | Hold |
562
| – | – | 0.01% | 196 |
|
|
2018
Q1 | $27K | Hold |
562
| – | – | 0.01% | 190 |
|
|
2017
Q4 | $25K | Buy |
+562
| New | +$26K | 0.01% | 192 |
|
|
2017
Q2 | – | Sell |
-150
| Closed | -$8K | – | 321 |
|
|
2017
Q1 | $8K | Buy |
+150
| New | +$7.61K | ﹤0.01% | 215 |
|
|
2016
Q2 | – | Sell |
-108
| Closed | -$5K | – | 370 |
|
|
2016
Q1 | $5K | Buy |
+108
| New | +$5.38K | ﹤0.01% | 348 |
|
|
2013
Q4 | – | Sell |
-26
| Closed | -$2K | – | 249 |
|
|
2013
Q3 | $2K | Buy |
+26
| New | +$1.67K | ﹤0.01% | 228 |
|
Other funds holding GSK
JEST
NewSquare Capital's GSK Position: Q1 2026 in Review
NewSquare Capital increased its GSK (GSK) stake by 4.6% in Q1 2026, buying an estimated $65.4K and bringing the position to 27,626 shares worth $1.52M. The position accounts for 0.13% of the portfolio, ranked #128.
NewSquare Capital first reported a position in GSK in Q3 2013 and has held it in 36 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- NewSquare Capital held 27,626 shares of GSK worth $1.52M as of Q1 2026.
- NewSquare Capital bought 1,206 GSK shares in Q1 2026, an estimated $65.4K.
- GSK made up 0.13% of NewSquare Capital's portfolio in Q1 2026, its #128 holding.
- NewSquare Capital first reported a position in GSK in Q3 2013 and has held it in 36 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on NewSquare Capital's 13F filing for Q1 2026, filed 8 May 2026.